Bayer Statement on Supreme Court Decision to Deny Review of Hardeman Case
Print this Article | Send to Colleague
On Tuesday, the Supreme Court denied review of an appeal for the Hardeman case. This let's stand a multimillion-dollar verdict against the manufacturer of the popular weedkiller Roundup for failing to warn of cancer risks. In response the manufacturer, Bayer, released a statement disagreeing with the decision, stating "The company believes that the decision undermines the ability of companies to rely on official actions taken by expert regulatory agencies, as it permits every U.S. state to require a different product label, which conflicts with the clear intent of the ‘uniformity clause’ adopted by the U.S. Congress in FIFRA and similar statutes." In the same press release Bayer also details its plan for the future, "With its five-point plan, the company is fully prepared to manage the litigation risk associated with potential future claims in the U.S. as previously communicated in July 2021." While this particular case focuses on herbicides, a chemical not typically used in the Pest Management Industry, this does set a bad precedent for labels ongoing in the future.
